Cargando…

Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices

INTRODUCTION: Atrial high-rate episodes (AHREs) are associated with an increased risk of developing atrial fibrillation and thromboembolism. The characteristics of ‘real world’ patients developing AHREs are poorly known. METHODS: We included 496 consecutive patients with cardiac implantable electron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pastori, Daniele, Miyazawa, Kazuo, Li, Yanguang, Shahid, Farhan, Hado, Hussein, Lip, Gregory Y. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105258/ https://www.ncbi.nlm.nih.gov/pubmed/29667016 http://dx.doi.org/10.1007/s00392-018-1244-0

Ejemplares similares

Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes
por: Miyazawa, Kazuo, et al.
Publicado: (2019)

Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices
por: Miyazawa, Kazuo, et al.
Publicado: (2021)

Identifying At‐Risk Patients for Sustained Atrial High‐Rate Episodes Using the C(2)HEST Score: The West Birmingham Atrial Fibrillation Project
por: Li, Yan‐Guang, et al.
Publicado: (2021)

Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
por: Khan, Ahsan A., et al.
Publicado: (2019)

Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation
por: Imberti, Jacopo Francesco, et al.
Publicado: (2022)

Effects of antiarrhythmics on atrial high rate episodes and progression to clinical atrial fibrillation (ANTI-AHRE)
por: Simovic, S, et al.
Publicado: (2023)

HATCH Score and Left Atrial Size Predict Atrial High-Rate Episodes in Patients With Cardiac Implantable Electronic Devices
por: Chen, Ju-Yi, et al.
Publicado: (2021)

The performance of five models compared with atrial high rate episodes predicts new atrial fibrillation after cardiac implantable electronic devices implantation
por: Chen, Ju‐Yi, et al.
Publicado: (2022)

Prevalence and Predictors of Clinically Relevant Atrial High-Rate Episodes in Patients with Cardiac Implantable Electronic Devices
por: Kim, Min, et al.
Publicado: (2020)

Role of Monocytes in Heart Failure and Atrial Fibrillation
por: Shahid, Farhan, et al.
Publicado: (2018)

Artificial intelligence predicts clinically relevant atrial high-rate episodes in patients with cardiac implantable electronic devices
por: Kim, Min, et al.
Publicado: (2022)

Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project
por: Shahid, Farhan, et al.
Publicado: (2018)

Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention
por: Shahid, Farhan, et al.
Publicado: (2016)

Role of the monocyte-to-high-density lipoprotein ratio in predicting atrial high-rate episodes detected by cardiac implantable electronic devices
por: Satilmis, Seckin
Publicado: (2018)

Prevalence of atrial high‐rate episodes and the risk factors in Indian patients with cardiac implantable electronic devices: Real‐world data
por: Banerjee, Suvro, et al.
Publicado: (2019)

Atrial high-rate episodes and stroke prevention
por: Camm, A. John, et al.
Publicado: (2017)

Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists
por: Zulkifly, Hanis H., et al.
Publicado: (2023)

The Differential Prognostic Impact of Long-Duration Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices between Patients with and without a History of Atrial Fibrillation
por: Ishiguchi, Hironori, et al.
Publicado: (2022)

Monocyte/High-Density Lipoprotein Ratio Is Associated with Atrial High-Rate Episodes within One Year Detected by Cardiac Implantable Electronic Devices
por: Ji, Lishuang, et al.
Publicado: (2023)

What do we do about atrial high rate episodes?
por: Boriani, Giuseppe, et al.
Publicado: (2020)

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation
por: Black‐Maier, Eric, et al.
Publicado: (2017)

Performance of the HAS‐BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and Cancer: Data From the French National Hospital Discharge Database
por: Pastori, Daniele, et al.
Publicado: (2022)

Performance of an implantable automatic atrial fibrillation detection device: impact of software adjustments and relevance of manual episode analysis
por: Eitel, Charlotte, et al.
Publicado: (2011)

Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation
por: Fernández-Gallego, Nieves, et al.
Publicado: (2021)

Serotonin antidepressants and atrial fibrillation burden from cardiac implantable electronic devices
por: Koh, Youlin, et al.
Publicado: (2023)

mHealth based patient-centered self-management reduces the burden and episodes of atrial fibrillation
por: Guo, Y, et al.
Publicado: (2022)

Atrial high-rate episodes predict major adverse cardio/cerebrovascular events in patients with cardiac implantable electrical devices
por: Chen, Ju-Yi, et al.
Publicado: (2021)

AhR-deficiency as a cause of demyelinating disease and inflammation
por: Juricek, Ludmila, et al.
Publicado: (2017)

Percutaneous left atrial appendage occlusion in patients with a cardiac implantable electronic device
por: Staal, D. P., et al.
Publicado: (2023)

Stroke risk in patients with device-detected atrial high-rate episodes
por: Erküner, Ö., et al.
Publicado: (2017)

Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial
por: Kirchhof, Paulus, et al.
Publicado: (2017)

Cardiac implantable electronic device implantation and device-related infection
por: Modi, Vivek, et al.
Publicado: (2023)

Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review
por: Violi, Francesco, et al.
Publicado: (2016)

Implantable Electronic Medical Devices
por: Fitzpatrick, Dennis
Publicado: (2014)

Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS‐AF Trial
por: Shantsila, Eduard, et al.
Publicado: (2020)

Association between atrial fibrillation and healthcare costs among patients with cardiac implantable electronic devices
por: Peigh, G, et al.
Publicado: (2023)

Cost-effectiveness analysis of cardiac implantable electronic devices with reactive atrial-based antitachycardia pacing
por: Noda, Takashi, et al.
Publicado: (2023)

Cardiac Electronic Devices: Future Directions and Challenges
por: Kotalczyk, Agnieszka, et al.
Publicado: (2020)

Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation
por: Puccetti, Matteo, et al.
Publicado: (2022)

NARROWING RACIAL AND ETHNIC DISPARITIES IN HOME AND COMMUNITY-BASED SERVICES
por: Hado, Edem
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ji0e4bt2i7cf2lhockk0qte94